The Food and Drug Administration (FDA) and Department of Health and Human Services hold a public advisory committee meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee from 9:30 a.m. to 1:30 p.m. ET on May 10. The committees discuss supplemental new drug application (sNDA) 017031/S-041, for OPILL…
LIVE 9:30 AM ET: FDA, HHS Advisory Board Meeting on Nonprescription Birth Control Pill (Day 2)
LIVE NOW: FDA, HHS Advisory Board Meeting on Nonprescription Birth Control Pill (Day 2)
The Food and Drug Administration (FDA) and Department of Health and Human Services hold a public advisory committee meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee from 9:30 a.m. to 1:30 p.m. ET on May 10. The committees discuss supplemental new drug application (sNDA) 017031/S-041, for OPILL…
FDA, HHS Advisory Board Meeting on Nonprescription Birth Control Pill (Day 2)
The Food and Drug Administration (FDA) and Department of Health and Human Services hold a public advisory committee meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee from 9:30 a.m. to 1:30 p.m. ET on May 10. The committees discuss supplemental new drug application (sNDA) 017031/S-041, for OPILL…
LIVE 9:30 AM ET: FDA, HHS Advisory Board Meeting on a Nonprescription Birth Control Pill
The Food and Drug Administration (FDA) and Department of Health and Human Services hold a public advisory committee meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee from 9:30 a.m. to 5:30 p.m. ET on May 9. The committees discuss supplemental new drug application (sNDA) 017031/S-041, for OPILL…
LIVE NOW: FDA, HHS Advisory Board Meeting on a Nonprescription Birth Control Pill
The Food and Drug Administration (FDA) and Department of Health and Human Services hold a public advisory committee meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee from 9:30 a.m. to 5:30 p.m. ET on May 9. The committees discuss supplemental new drug application (sNDA) 017031/S-041, for OPILL…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`